SCHEMBL17265202

SCHEMBL17265202

Cc1cc(C)c(-c2cccc(Br)c2O)c(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 2/20 0.39
ALDH1A1 P00352 5/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PDK2 Q15119 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
ELANE P08246 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
MEN1 O00255 1/20 0.37
USP2 O75604 1/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
BRCA1 P38398 1/20 0.37
RECQL P46063 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6745620 0.86 ALDH1A1 (0.44) RAPGEF4ALDH1A1L3MBTL1PDK2KDM4E
SCHEMBL9743119 0.81 TRPA1 (0.50) RAPGEF4ALDH1A1L3MBTL1PDK2CA1
SCHEMBL28600277 0.80 ALDH1A1 (0.46) RAPGEF4ALDH1A1L3MBTL1PDK2MAPT
SCHEMBL13044877 0.79 GABRA1 (0.41) ALDH1A1CA1CA2KDM4EMAPT
SCHEMBL27404519 0.78 RAPGEF4 (0.40) RAPGEF4ALDH1A1PDK2KDM4EMAPT
SCHEMBL22855607 0.78 HKDC1 (0.36) RAPGEF4ALDH1A1L3MBTL1PDK2KDM4E
SCHEMBL30485469 0.78 HKDC1 (0.36) RAPGEF4ALDH1A1L3MBTL1PDK2KDM4E
SCHEMBL11323890 0.75 CA1 (0.45) ALDH1A1PDK2CA1CA2CA7
SCHEMBL30578879 0.74 ALOX5 (0.41) ALDH1A1L3MBTL1PDK2MAPTELANE
SCHEMBL11785835 0.72 PDK2 (0.45) ALDH1A1L3MBTL1PDK2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3143006-B1 SYNTHESIS OF ARYL COUPLED BIS PHENOXIDES AND THEIR USE IN OLEFIN POLYMERIZATION CATALYST SYSTEMS WITH ACTIVATOR-SUPPORTS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2018-07-25 EP disclosed
US-9663594-B2 Synthesis of aryl coupled bis phenoxides and their use in olefin polymerization catalyst systems with activator-supports CHEVRON PHILIPS CHEMICAL COMPANY LP (US) 2017-05-30 US disclosed
US-9663594-B2 Synthesis of aryl coupled bis phenoxides and their use in olefin polymerization catalyst systems with activator-supports CHEVRON PHILIPS CHEMICAL COMPANY LP (US) 2017-05-30 US disclosed
US-20160289351-A1 Synthesis of Aryl Coupled BIS Phenoxides and Their Use in Olefin Polymerization Catalyst Systems With Activator-Supports CHEVRON PHILLIPS CHEMICAL COMPANY LP 2016-10-06 US disclosed
US-20160289351-A1 Synthesis of Aryl Coupled BIS Phenoxides and Their Use in Olefin Polymerization Catalyst Systems With Activator-Supports CHEVRON PHILLIPS CHEMICAL COMPANY LP 2016-10-06 US disclosed
US-9394387-B2 Synthesis of aryl coupled bis phenoxides and their use in olefin polymerization catalyst systems with activator-supports CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2016-07-19 US disclosed
US-9394387-B2 Synthesis of aryl coupled bis phenoxides and their use in olefin polymerization catalyst systems with activator-supports CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2016-07-19 US disclosed
US-20150329652-A1 Synthesis of Aryl Coupled BIS Phenoxides and Their Use in Olefin Polymerization Catalyst Systems With Activator-Supports CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2015-11-19 US disclosed
US-20150329652-A1 Synthesis of Aryl Coupled BIS Phenoxides and Their Use in Olefin Polymerization Catalyst Systems With Activator-Supports CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2015-11-19 US disclosed
WO-2015175636-A1 SYNTHESIS OF ARYL COUPLED BIS PHENOXIDES AND THEIR USE IN OLEFIN POLYMERIZATION CATALYST SYSTEMS WITH ACTIVATOR-SUPPORTS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2015-11-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329652-A1 Synthesis of Aryl Coupled BIS Phenoxides and Their Use in Olefin Polymerization Catalyst Systems With Activator-Supports PPOX, AOC2, AOC3 RAPGEF4 446/4885ALDH1A1 1691/4885L3MBTL1 4380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.